NEOGENOMICS INC
Datakwaliteit: 83%
NEO
NASDAQ
Services
Engineering & Management Services
€ 8,41
▼
€ 0,28
(-3,17%)
6 months return
—
Momentum
Neutral
ROE
-12,77%
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-12,77%
Boven sectorgemiddelde (-16,21%)
ROIC-7,12%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio3,91
Interest Coverage-30,88
Waardering
PE (TTM|NTM|2027)
-9,63 | 26,82 | 24,72
Onder sectorgemiddelde (-1,19)
P/B Ratio1,24
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Negative free cash flow of -21,78 M
Price History
Financiële Trends
Koersdoel Analisten
8 analisten
Buy
+71.8%
upside to target
Huidig
€ 8,41
Consensus Target
€ 14,44
€ 13,00
Laag
€ 17,00
Hoog
Vooruitzicht
Forward K/W
26,82
Forward WPA
€ 0,32
WPA Groei (sch.)
+104,6%
Omzet Sch.
875,30 M
Winstverassingen
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: € 0,00
·
Rev Est: 184,51 M
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | € 0,00 | € 0,03 | € 0,03 | € 0,06 | — | — |
| Estimate | -€ 0,01 | € 0,02 | € 0,02 | € 0,04 | € 0,00 | € 0,04 |
| Verrassing | +100,00% | +21,85% | +25,79% | +50,00% | — | — |
Growth
Rev 5Y: N/A · Earnings 1Y: N/A
Growth
Rev 5Y: N/A · Earnings 1Y: N/A| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
Profitability
ROE: -12,77% · Net Margin: N/A
Profitability
ROE: -12,77% · Net Margin: N/A| Revenue (TTM) | N/A | Net Income (TTM) | -108,03 M |
| ROE | -12,77% | ROA | -7,80% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -21,78 M |
| ROIC | -7,12% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 3,91
Safety
D/E: N/A · Current: 3,91| Debt / Equity | N/A | Current Ratio | 3,91 |
| Interest Coverage | -30,88 | Asset Turnover | N/A |
| Working Capital | 284,60 M | Tangible Book Value | 19,78 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -9,63 · EV/EBITDA: N/A
Valuation
P/E: -9,63 · EV/EBITDA: N/A| P/E Ratio | -9,63 | Forward P/E | 26,82 |
| P/B Ratio | 1,24 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | 0,26 |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 1,19 | Fwd Earnings Yield | 3,73% |
| FCF Yield | -2,09% | ||
| Market Cap | 1,04 B | Enterprise Value | 876,38 M |
Per Share
EPS: N/A · FCF/Share: -0,17
Per Share
EPS: N/A · FCF/Share: -0,17| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | -0,17 | OCF / Share | 0,04 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 20,16% · CapEx/Rev: N/A
Efficiency
FCF Conv: 20,16% · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | 20,16% |
| SBC-Adj. FCF | -63,52 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net Income | -108,03 M | -78,73 M | -87,97 M | -144,25 M | -8,35 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | 314,29 M | 290,10 M | 244,60 M | 187,90 M | 187,06 M |
| Operating Income | -115,88 M | -92,11 M | -107,74 M | -157,62 M | -118,75 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 37,08 M | 31,16 M | 27,31 M | 30,33 M | 21,87 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 3,75 M | 6,62 M | 6,91 M | 1,51 M | 5,08 M |
| Income Tax | -2,24 M | -1,95 M | -9,13 M | -15,09 M | -6,73 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,36 B | 1,64 B | 1,68 B | 1,74 B | 1,87 B |
| Total Liabilities | 523,27 M | 735,70 M | 739,69 M | 742,01 M | 761,50 M |
| Shareholders' Equity | 836,56 M | 902,34 M | 941,54 M | 998,02 M | 1,11 B |
| Total Debt | 341,86 M | 541,11 M | — | — | — |
| Cash & Equivalents | 159,62 M | 367,01 M | 342,49 M | 263,18 M | 316,83 M |
| Current Assets | 376,29 M | 596,02 M | 596,81 M | 605,29 M | 681,51 M |
| Current Liabilities | 88,30 M | 301,24 M | 96,30 M | 89,93 M | 87,23 M |
Sectorvergelijking
vs Services sector mediaan (615 peers)
Vergeleken met vergelijkbare bedrijven in Services
Sectorvergelijking
vs Services sector mediaan (615 peers) Vergeleken met vergelijkbare bedrijven in Services| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -9,6 | -1,2 |
| P/B | 1,2 | 1,4 |
| ROE % | -12,8 | -16,2 |
| Net Margin % | — | -19,4 |
| Rev Growth 5Y % | — | 4,0 |
| D/E | — | 0,4 |
ETFs Holding This Stock
ETFs Holding This Stock
{"event":"ticker_viewed","properties":{"ticker":"NEO","listing_kind":"stock","pathname":"/stocks/neo","exchange":"NASDAQ","country":"US"}}